Literature DB >> 19786653

How to treat hormone receptor-positive, human epidermal growth factor receptor 2-amplified breast cancer.

Javier Cortes, José Baselga.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786653     DOI: 10.1200/JCO.2009.23.8089

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Lapatinib: in postmenopausal women with hormone receptor-positive, HER2-positive metastatic breast cancer.

Authors:  Monique P Curran
Journal:  Drugs       Date:  2010-07-30       Impact factor: 9.546

Review 2.  HER2 and hormone receptor-positive breast cancer--blocking the right target.

Authors:  Javier Cortés; Cristina Saura; Meritxell Bellet; Eva Muñoz-Couselo; Natalia Ramírez-Merino; Virginia Calvo; Jose Pérez; María Vidal
Journal:  Nat Rev Clin Oncol       Date:  2010-12-14       Impact factor: 66.675

Review 3.  Advances in first-line treatment for patients with HER-2+ metastatic breast cancer.

Authors:  Leticia De Mattos-Arruda; Javier Cortes
Journal:  Oncologist       Date:  2012-04-20

4.  Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2.

Authors:  Elena Shagisultanova; Lyndsey S Crump; Michelle Borakove; Jessica K Hall; Aryana R Rasti; Benjamin A Harrison; Peter Kabos; Traci R Lyons; Virginia F Borges
Journal:  Mol Cancer Ther       Date:  2021-11-02       Impact factor: 6.261

5.  Comparative study between quantitative digital image analysis and fluorescence in situ hybridization of breast cancer equivocal human epidermal growth factor receptors 2 score 2(+) cases.

Authors:  Essam Ayad; Mina Mansy; Dalal Elwi; Mostafa Salem; Mohamed Salama; Klaus Kayser
Journal:  J Pathol Inform       Date:  2015-06-03

Review 6.  Overcoming Therapeutic Resistance of Triple Positive Breast Cancer with CDK4/6 Inhibition.

Authors:  Troy B Schedin; Virginia F Borges; Elena Shagisultanova
Journal:  Int J Breast Cancer       Date:  2018-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.